WO1996015829A2 - Procede d'induction de champs electriques a courant continu dans une matiere biologique et procede d'utilisation - Google Patents
Procede d'induction de champs electriques a courant continu dans une matiere biologique et procede d'utilisation Download PDFInfo
- Publication number
- WO1996015829A2 WO1996015829A2 PCT/US1995/015811 US9515811W WO9615829A2 WO 1996015829 A2 WO1996015829 A2 WO 1996015829A2 US 9515811 W US9515811 W US 9515811W WO 9615829 A2 WO9615829 A2 WO 9615829A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- biological material
- magnetic field
- magnetic
- electromagnets
- array
- Prior art date
Links
- 239000012620 biological material Substances 0.000 title claims abstract description 76
- 230000005684 electric field Effects 0.000 title claims abstract description 58
- 238000000034 method Methods 0.000 title claims abstract description 34
- 230000001939 inductive effect Effects 0.000 title claims abstract description 10
- 230000005291 magnetic effect Effects 0.000 claims abstract description 145
- 239000000463 material Substances 0.000 claims abstract description 49
- 241001465754 Metazoa Species 0.000 claims abstract description 12
- 230000007246 mechanism Effects 0.000 claims abstract description 11
- 230000004913 activation Effects 0.000 claims abstract description 8
- 210000001519 tissue Anatomy 0.000 claims description 26
- 210000004027 cell Anatomy 0.000 claims description 18
- 230000002093 peripheral effect Effects 0.000 claims description 18
- 210000000988 bone and bone Anatomy 0.000 claims description 14
- 210000001124 body fluid Anatomy 0.000 claims description 13
- 239000010839 body fluid Substances 0.000 claims description 13
- 239000000696 magnetic material Substances 0.000 claims description 12
- 241000282412 Homo Species 0.000 claims description 4
- 239000003814 drug Substances 0.000 description 11
- 229940079593 drug Drugs 0.000 description 11
- 239000013598 vector Substances 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 238000004804 winding Methods 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 3
- 239000004020 conductor Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000011152 fibreglass Substances 0.000 description 3
- 239000003292 glue Substances 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 210000003050 axon Anatomy 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 229910052796 boron Inorganic materials 0.000 description 2
- 230000005294 ferromagnetic effect Effects 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 206010007710 Cartilage injury Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- 229910001209 Low-carbon steel Inorganic materials 0.000 description 1
- 206010028331 Muscle rupture Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010033892 Paraplegia Diseases 0.000 description 1
- QJVKUMXDEUEQLH-UHFFFAOYSA-N [B].[Fe].[Nd] Chemical compound [B].[Fe].[Nd] QJVKUMXDEUEQLH-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000002801 charged material Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000005672 electromagnetic field Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229910001172 neodymium magnet Inorganic materials 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000007505 plaque formation Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 229910052761 rare earth metal Inorganic materials 0.000 description 1
- 150000002910 rare earth metals Chemical class 0.000 description 1
- 230000007420 reactivation Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 208000020431 spinal cord injury Diseases 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/12—Magnetotherapy using variable magnetic fields obtained by mechanical movement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
- A61N1/303—Constructional details
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
Definitions
- the present invention relates to apparatus and methods for generating direct current (DC) electric fields in biological material. More specifically, the invention relates to apparatus and methods that create moving magnetic fields and generate DC electric fields in biological material for medical treatment or for inducing the transportation of medicants.
- DC direct current
- DC currents are recognized as providing medicinal benefits when applied to biological materials. For example, DC currents applied on or beneath the skin's surface have been effective in promoting the rapid healing of bones and tissues, and even the regrowth of severed spinal cord axons. The most significant beneficial results are obtained through the application of DC currents that mimic the body's own mechanism.
- Typical apparatus have relied on electrode imposed electric fields to impart the electromotive force required to produce the DC electric currents in treated tissues.
- the electrodes are inserted into the material being treated, e.g., beneath the skin.
- the use of electrodes to induce electrical currents to treat spinal cord injuries is disclosed in Borgens et al. , "Applied Electric Fields in Clinical Cases of Complete Paraplegia in Dogs.” Restorative Neurolo ⁇ v and Neuroscience. Vol. 5, pp. 305-322 (1993) .
- the invasive nature of electrodes threatens the beneficial outcome of the clinical treatment and production of uniform DC or rectified AC electric current within the material being treated.
- the electrodes can - 2 -
- the fields produced are non-uniform in both intensity and geometry.
- such electrodes polarize and surround the electrode with oppositely charged ions weakening the field and rendering it non-uniform.
- the present invention is directed to apparatus and methods for inducing DC electric fields in living cells that substantially obviates one or more of the problems due to limitations and disadvantages of the related art .
- the present invention provides a device that allows the production of a DC electric field within biological material, such as living cells and tissue, to obtain a desired clinical benefit without the use of invasive electrodes. This allows for the generation of electric current which mimics the natural mechanism of the cell or tissue. In addition, the present invention avoids the side effects associated with electrodes, such as infection.
- the invention provides an apparatus of either permanent or electromagnets arranged and prepared so as to cause the spatial movement of the arranged or generated magnetic fields relative to the material in which the desired DC electric field is to be induced.
- the movement of such fields by the apparatus induces a Lorentz force on electrons within living cells and tissue exposed to this force and generates a direct current in the cells or tissue.
- the invention may include an apparatus for treatment where the magnets are permanent magnetic material with coercivity greater than 1 kOe.
- the invention may include an apparatus for treatment where the magnets are a plurality of electromagnets.
- the invention may include an apparatus for treatment including at least one driven disk-like member with an outer peripheral surface where magnetic material on the surface is made up of discrete permanent magnets.
- the invention may include an apparatus for treatment including at least one driven disk-like member with a groove on its outer peripheral surface, where the magnetic material of discrete permanent magnets is on the surface of the groove.
- the invention may include an apparatus for treatment including at least one driven disk-like member with an outer peripheral surface where magnetic material on the surface is made up of a plurality of electromagnets.
- the invention may include an apparatus for treatment including at least one driven disk-like member with a groove on its outer peripheral surface, where the magnetic material on the surface of the groove is made up of a plurality of electromagnets.
- the invention in another embodiment, includes a sequential array of electromagnets in proximity to the biological material to be treated, a magnet control device disposed to sequentially apply a pulse of electrical current to each electromagnetic in the array in order to generate a moving magnetic field along the array so as to induce a direct electric field within the treated material by the movement of magnetic fields from the electromagnetic.
- FIG. 1 is a schematic perspective view of an embodiment of the invention where the moving magnetic field is generated by a plurality of permanent magnets forming a portion of the outer peripheral surface of a rotating disk-like member.
- FIG. 2 is a cross-sectional view of the disk-like member of FIG. 1 taken along line II-II.
- FIG. 3 is a perspective view of another embodiment of the invention where the moving magnetic field is generated by a continuous permanent magnet forming the outer peripheral surface of a rotating disk-like member.
- FIG. 4 is a cross-sectional view of the disk of FIG. 3 taken along line IV-IV.
- FIG. 5 is a perspective view of another embodiment of the present invention where the member creating the moving magnetic field comprises a rotating disk having a V-shaped outer peripheral surface with a plurality of permanent magnets affixed within the V.
- FIG. 6 is a cross-sectional view of the disk of FIG. 5 taken along line VI-VI.
- FIG. 7 is a perspective view of another embodiment of the invention where the device for forming the moving magnetic field comprises a rotating disk-like member having a V-shaped groove in its outer peripheral surface with each of the V-shaped surfaces comprised of a continuous permanent magnet .
- FIG. 8 is a cross-sectional view of the disk of FIG. 7 taken along line VIII-VIII.
- FIG. 9 is a perspective view of another embodiment of the present invention having a plurality of rotating disk-like members that induce a moving magnetic field within the arm of a human.
- FIG. 10 is a cross-sectional view of the embodiment of FIG. 9 along line X-X with the flux lines formed by the rotating magnets schematically depicted.
- FIG. 11 is a schematic perspective view of another embodiment of the invention where the moving magnetic field is generated by a belt-like member including a continuous magnetic material .
- FIG. 12 is a cross-sectional view of a rotating member of FIG. 11 with the belt thereon.
- FIG. 13 is a perspective view of the embodiment of FIG. 11 where the moving magnetic field is formed by a plurality of permanent magnets affixed to an endless belt.
- FIG. 14 is a cross-sectional view of the embodiment of FIG. 13 taken along line XIV-XIV.
- FIG. 15 is a schematic depiction of an embodiment of the invention having an array of electromagnets and a schematic control system used to generate a moving magnetic field by the use of electromagnets.
- FIG. 16 is a cross-sectional view of the embodiment of FIG. 15 taken along line XVI-XVI.
- FIG. 17 is a perspective view of an embodiment of the invention where the moving magnetic field is generated by a magnet on a rotating disk.
- FIG. 18 is a cross-sectional view of the embodiment of FIG. 17 taken along line XVIII-XVIII.
- FIG. 19 is a schematic view of the embodiment of FIGS. 17 and 18 depicting the configuration of the magnetic member.
- FIG. 20 is a perspective view of a transdermal medicant delivery device using a moving magnetic field to induce the transportation of the medicant.
- FIG. 21 is a cross-sectional view of the device of FIG. 21.
- the present invention creates a DC electric field in biological material to treat the material.
- the biological material can be portions of a living human or animal, such as body fluids, cells, tissue, or bone.
- the DC electric field can treat the biological material in numerous ways, including promoting regeneration of damaged tissue.
- the DC electric field can treat trauma (e.g., bruises, torn muscles, and cartilage damage) ; debilitation; organs by stimulating their regeneration to restore or enhance their functions; damaged or severed human nerves or axons; slow healing bone fractures (nonunions) ,* occlusion of blood flow due to the formation of plaque or other forms of calcification in the blood stream; ailments, such as heart disease and senility, resulting from reduced blood flow to the affected organ; or osteoporosis (both prevention and reversal) .
- trauma e.g., bruises, torn muscles, and cartilage damage
- debilitation organs by stimulating their regeneration to restore or enhance their functions
- damaged or severed human nerves or axons e.g., torn muscles, and cartilage damage
- slow healing bone fractures e.g., fractures, torn muscles, and carti
- the electric field can also be used to treat the biological material by destroying it or disrupting its normal processes.
- it can be used to treat cancerous tissues within the human body by means of high electric currents.
- the electric field can also be used to increase migration of electrically charged materials through the biological material.
- the electric field can allow or enhance transdermal transport of efficacious ionic drug components to specific locations within the tissue, thus reducing the amount of drug needed as well as toxic effects from the drug.
- the electric field can also be used to decrease human nerve pain by blocking electrical signals along nerve paths.
- the present invention creates the DC electric field in the biological material by subjecting it to a moving magnetic field. Ions moving through a magnetic field are acted on by a Lorentz force. This force is usually stated in vector form:
- the electromotive force will act on any electric charges within the moving magnetic field to create electric currents.
- the moving magnetic field creates a DC electric field in the biological material.
- the present invention contemplates two different methods of generating the moving magnetic field to form the DC electric field: (1) moving magnet (s) through space; and (2) sequentially activating an array of electromagnets.
- Embodiments of the invention using the first method of forming a moving magnetic field are depicted in FIGS. 1 through 14 and 17 through 21.
- the present invention includes at least one magnet for creating a magnetic field that can pass through the biological material and a drive mechanism for moving the magnet relative to the material to induce a DC electric field within the material by means of the movement of the magnetic field.
- the at least one magnet for creating a magnetic field is preferably a permanent, rare earth magnet 40, having a coercivity of greater than 1 kOe.
- the magnet 40 is neodymium-iron-boron (Ne_Fe .B) .
- Ne_Fe .B neodymium-iron-boron
- other permanent magnets of lesser strength can be used.
- the embodiments of the invention disclosed and explained herein that practice the first method of forming a moving magnetic field use permanent magnets. However, the invention can also be carried out by replacing the permanent magnets with electromagnets. Any conventional electromagnet can be used that has the required strength. Preferably a plurality of electromagnets are utilized. The electromagnets should be connected, by conventional connections, to a power source.
- the drive mechanism for moving the magnet 40, 40', 40'', or 40''' relative to the material includes a disk-like member 30, 30', 30"', or 30''' or belt-like member 60 or 60' for holding the magnet, and a device for driving the disk-like member or belt-like member.
- FIGS. 1 through 14 and 17 through 21 Various embodiments of rotating disk-like members 30, 30', 30'', or 30''' for holding the magnet are shown in FIGS. 1 through 14 and 17 through 21.
- the disk-like members preferably are made of mild steel or iron. The operation of the apparatus using disk-like members will be explained by reference to the embodiment shown in FIGS. 1 and 2.
- the disk-like member 30 depicted in FIGS. 1 and 2 has a plurality of discrete, permanent magnets 40 arranged in a circular array on its rim or outer peripheral surface.
- the magnets 40 preferably are closely and equidistantly spaced.
- each magnet 40 is a rectangular slab. However, different shapes can be used to suit the application of the apparatus.
- the magnets 40 are positioned in rectangular slots 42 machined in the rim of the disk-like member 30.
- Each magnet 40 preferably is glued into each slot 42 with a high quality glue.
- other conventional connectors can be used.
- the north magnetic poles of all of the magnets 40 are located on the magnets' outer surfaces and the south magnetic poles are located on the opposite inner surfaces that are in contact with the surface of the disk-like member 30.
- this embodiment would have to be modified to have a single continuous strip with a single outward facing magnetic pole as in the embodiment shown in FIGS. 3 and 4. If the application of the apparatus requires a reversing AC equivalent electric field, the magnets 40 will reverse polarity in such fashion as to generate the desired field pattern.
- the device for driving the disk-like member 30 preferably includes a conventional electric motor 50 connected to a variable speed control device 70.
- the speed control device is adjustable through a wide range of rotary speeds and thereby can adjust the induced current.
- the rotation of the motor 50 is translated to the disk-like member 30 by means of a shaft 52 held in place by set screw 54.
- Supports 80 on each side of the motor 50 provide a rigid mount and sufficient clearance for free rotation of disk-like member 30.
- the rotation of the disk-like member 30 moves the permanent magnets 40, thus inducing an associated electric field in the biological material by the Lorentz phenomenon.
- the amplitude of the DC electric current may vary due to variations in flux from the individual magnets on a peripheral surface of the disk. However, a DC electric field is generated, and an electric current generated thereby, as a result of the rotation of the disk-like member 30.
- 0 is the radial velocity and, r is the radius of the disk-like member.
- the disk-like member preferably is encased in a casing (not shown) that shields the biological material from the rotating disk-like member 30.
- the casing is preferably formed from a non-conducting material, such as glass reinforced plastic or some other non-magnetic structural plastic, preferably having a thickness no greater than one eighth inch (1/8").
- the clearance between the casing and the outer surface of magnets preferably is no greater than one eighth inch (1/8") .
- FIGS. 3 and 4 Another embodiment of the disk-like member 30' of the present invention is depicted in FIGS. 3 and 4, wherein a continuous magnet 40' forms the major portion of the rim or outer peripheral surface of the disk-like member 30' .
- the magnet 40' is preferably glued in a single slot machined in the rim of the disk-like member 30' .
- the magnet 40' is a single continuous strip with a single outward facing magnetic pole.
- the magnet 40' preferably has its north and south poles facing outwardly and inwardly, respectively, which produces a true DC current output.
- FIGS. 5 and 6 An additional embodiment of the disk-like member 30'' of the present invention is depicted in FIGS. 5 and 6.
- the rim or outer peripheral surface of the disk-like member 30'' forms a V-shaped groove.
- a plurality of pairs of permanent magnets 40'' are arranged in a circular array within slots in the V-shaped groove.
- the magnets 40'' preferably are square slabs that are spaced equidistantly along the rim of disk-like member 30'' in closely fitted machined slots shown in FIG. 6. Different shapes can be used, however, to suit the application of the apparatus. Each magnet 40'' preferably is glued into each slot with a high quality glue. However, other suitable connectors can be used. To obtain DC current with a slight ripple, permanent magnets 40'' are mounted on the disk-like member 30'' such that magnets 40'' on opposing sides of the v-shaped groove are directly opposite each other.
- the magnets 40'' are also arranged so that all magnets 40'' on one side of the V-shaped groove have their north magnetic poles facing outwardly and all magnets 40"' on the other side of the V-shaped groove have their south magnetic poles facing inwardly.
- magnets 40'' are attracting in all cases and an endless series of closely spaced transverse magnetic fields are formed in the space between the two inner surfaces.
- the discrete magnets of this embodiment would have to be modified to be two individual continuous strips, each having a single outward facing magnetic pole, as in the embodiment shown in FIGS. 7 and 8. If the application requires a reversing AC equivalent electric field the magnets 8 will reverse polarity is such fashion as to generate the desired field pattern.
- the magnetic field between the opposing magnets 40'' forms a semicircular arc above the outer rim of the disk-like member 30''.
- the magnetic field's shape and extension above the rim of the disk-like member 30'' is controlled by the angle between the surfaces of the opposing magnets 40''.
- the magnets are mounted at an angle ⁇ relative to one another. That is, an angle ⁇ is formed between the planes formed by the outer surfaces of the magnets 40'' .
- the angle ⁇ varies between zero degrees and one hundred and eighty degrees (0° ⁇ ⁇ ⁇ 180°) , depending on the application of the apparatus.
- FIGS. 7 and 8 Another embodiment of the disk-like member 30''' is shown in FIGS. 7 and 8.
- the disk-like member 30''' has a V-shaped groove similar to the embodiment shown in FIGS. 5 and 6.
- the magnets 40''' in this embodiment are two continuous layers on each of the surfaces of the V-shaped groove.
- the magnet 40''' on one side of the V-shaped groove has its north magnetic pole facing outwardly and the magnet 40'''' on the other side of the V-shaped groove has its south magnetic pole facing outwardly.
- the magnets 40''' have opposing magnetic poles. This arrangement produces a true DC current output.
- FIGS. 9 and 10 depict a combination of the embodiments shown in FIGS. 3 and 5.
- the combination can be used to treat a human arm.
- the disk-like members 30'' are positioned opposite one another.
- the disk-like members 30' are also positioned opposite one another.
- the magnetic pole faces on one side of a plane perpendicular to the two drive axes of the disk-like members 30' are matched by opposite magnetic pole faces on the other side of that plane.
- the disk-like members 30' and 30'' produce a focused magnetic field having its greatest strength at a point or region of intersection 45 located equidistant from the magnetic surfaces.
- a synchronous system of drive mechanisms causes each disk-like member to rotate so that the magnetic fields from the disk-like members move in unison, in parallel, and in the same direction at the region of intersection 45.
- This embodiment concentrates the power of the magnetic field at the region of intersection 45. The concentrated power of the magnetic field allows the apparatus to generate strong electromotive forces within the biological material. This embodiment can be used, for example, to destroy tissue at specific locations.
- a physical barrier such as the casing described above is preferably positioned between the arm of the patient being treated and the disk-like members to prevent the arm of the patient from engaging the rotating disk-like members.
- the speed control and articulated mountings of disk-like members 30 and 30' also are not shown.
- FIGS. 17 and 19 show another embodiment of a system using a single disk-like member.
- This unitary, portable, rechargeable, magnetic treatment system has a magnetic disk 41 mounted on a side of a disk-like member 31.
- the magnetic disk 41 has only a single magnetic pole on the annular outer surface of the disk 41 facing outwardly from the disk-like member 31.
- the north magnetic pole faces outwardly and the south magnetic pole faces inwardly.
- This arrangement generates a true DC current in the biological material. If an AC current is desired, alternating segments of this surface annular will have opposing magnetic poles.
- the magnetic disk 41 preferably has a nominal radius of two to nine inches (2" to 9") .
- the disk-like member 31 is driven by an electric motor 50. As shown in FIGS. 18 and 19, electric motor 50 is mounted on housing 92. Shaft 93 from motor 50 turns worm gear 94, which drives gear 95 on disk-like member 31. The disk-like member 31 spins on bearing shaft 96.
- the motor 50 has a variable speed adjustment that allows for a variety of rotary speeds and resultant induced currents to select proper electric field strength for a specific treatment.
- Dial 97 adjusts the speed of the disk-like member 31 by varying the voltage from battery 98.
- Battery 98 is preferably rechargeable through port 99 or by removal and replacement.
- the magnetic disk 41 and disk-like member 31 are encased in a closely fitted housing 92 formed from non conducting material such as glass reinforced plastic or some other structural plastic.
- the inner surface of the face of the housing 92 that is most proximate and parallel to the outermost face of the magnetic disk 41 is covered by magnetic shielding 90, which prevents the passage of the magnetic field.
- the magnetic shielding 90 has one or more annular openings 91 that allow the magnetic disk's field to exit the housing 92 and penetrate the treated tissue. The number of openings can be altered as treatment may require.
- Embodiments of belt-like members 60 and 60' having permanent magnet (s) affixed thereto are shown in FIGS. 11 through 14.
- the belt-like members preferably are made of fiber-reinforced polymeric material, but any flexible material of sufficient strength would be adequate. The operation of the apparatus using belt-like members will be explained by reference to the embodiment shown in FIGS. 11 and 12.
- the belt-like member 60 has a single, continuous permanent magnetic strip 43 arranged on a flexible belt 65.
- the belt-like member 60 runs between disk-like members 66.
- the magnet 43 has a single outward facing magnetic pole.
- the north magnetic pole faces outwardly away from the belt 65 and the south magnetic pole is in contact with the surface of the belt 65.
- the magnet 43 preferably is fixed to the belt 65 with a high quality glue.
- the magnet 43 can be fixed to the belt 65 with any other suitable connector, such as rivets or staples.
- the belt-like member is preferably driven by two disk-like members 66 shown in FIG. 11.
- Each disk-like member 66 preferably is slightly wider than belt-like member 60.
- Both disk-like members 66 preferably are made of non-magnetic material, such as aluminum or a non ferrous material.
- the first disk-like member preferably is mounted on shaft 52 from an electric motor 50, having a variable speed adjustment that allows a wide assortment of rotary speeds.
- the second disk-like member preferably moves freely between two pillow blocks 68 on a shaft fitted to ball bearings in each pillow block 68.
- supports 80 on each side of the motor 50 and pillow blocks 68 on each side of the second disk-like member 66 provide a rigid mount and sufficient clearance for free rotation of disk-like members 68 and belt-like member 60.
- the belt and disk-like members of FIGS. 11 through 14 are preferably encased in a closely fitted, non-conducting material (not shown) , such as glass reinforced plastic or some other structural plastic, preferably having a thickness no greater than one eighth inch (1/8") .
- a closely fitted, non-conducting material such as glass reinforced plastic or some other structural plastic, preferably having a thickness no greater than one eighth inch (1/8") .
- the clearance between the encasing material and the outer surface of magnets preferably is no greater than one eighth inch (1/8") .
- the belt-like member 60' in this embodiment is a unitary system comprised of closely spaced, discrete, permanent magnets, all with the same polarity.
- Each magnet 40 is preferably a rectangular slab spaced equidistantly along the length of belt 65.
- different shapes can be used to suit the specific application of the apparatus. This arrangement produces a DC current with a slight ripple.
- the magnets of this embodiment would have to be modified to have the continuous, single magnetic pole shown in FIGS. 11 and 12. If the application requires a reversing AC equivalent electric field the magnets 40 will reverse polarity is such fashion as to generate the desired field pattern.
- FIGS. 15 and 16 depict an embodiment of the invention that sequentially activates an array of electromagnets to generate a moving magnetic field.
- the present invention includes a sequential array of electromagnets in proximity to the biological material, and a magnet control device disposed to sequentially apply a pulse of electrical current to each electromagnet in the array to generate a magnetic field in the electromagnet and, by the sequential activation of the electromagnets in the array, generate a moving magnetic field along the array thereby inducing a direct electric field within the material.
- the sequential array of electromagnets is formed by closely fitted, equidistantly spaced, C-shaped electromagnets 140.
- Each electromagnet 140 in the array can create a magnetic field, which is transverse to the longitudinal axis of the array, in the gap of the electromagnet. More specifically, energized magnetic inductance windings 142, which are protected by insulation 144, generate an electromagnetic field in the gap between ferromagnetic plates 146. Ferromagnetic spacer heads 148 narrow the gap and bring the magnetic field nearer to the biological material .
- the magnet control device includes a control box 170 that sends pulses of electrical current to windings 142 through connecting lines 141.
- the control box 170 has control settings 172 for controlling the amount of current sent to the windings 142 of the electromagnets 140 in the array.
- the control box 170 can control the magnetic field strength in the array.
- This embodiment of the invention achieves spatial translation of the magnetic field by the sequential activation of the electromagnets 140.
- the electromagnets 140 in the array are sequentially activated to move the magnetic field along the array.
- the control box 170 first sends current to the windings 142 of the first electromagnet 140 to create a magnetic field.
- the current to the first electromagnet 140 is then switched off and the second electromagnet 140 is energized within a specific switching time that is shorter than the natural rate at which the magnetic field decays (the e-folding time) .
- This causes the magnetic field lines, which would normally disburse from the first electromagnet 140, to be drawn along the longitudinal axis of the array to form the magnetic field in the second electromagnet 140.
- This process is repeated down the length of the array, thus creating a moving magnetic field that, though perpendicular to the longitudinal axis of the array, translates parallel to that axis along the length of the array.
- Subsequent magnetic fields are generated and moved along the array by reactivating the electromagnets 140, previously deactivated, after the prior magnetic field has moved along the array sufficient distance such that the subsequent magnetic field produced by reactivation of the electromagnets 140 will not significantly affect the prior moving magnetic field further along the array.
- the control settings 172 on the control box 170 determine which electromagnets 140 will be activated, and when. Thus, the control box 170 controls the velocity of the magnetic field by timing the activation of the electromagnets 140.
- the magnetic field strength and the velocity of the magnetic field which are both controlled by the control box 170, determine the intensity of the induced DC electric current in the biological material.
- the control box 170 controls the intensity of the DC electric current in the biological material.
- the velocity of the magnetic field is limited only by the e-folding time.
- the e-folding time establishes the maximum Lorentz forces that can be generated in the volume within the array.
- Growth and e-folding times for the magnetic coil inductances and electrical resistances of the circuit allow switching times and resulting magnetic field velocities that will generate induced electric currents far in excess of the requirements thus far established in research with direct application of electric currents.
- the C-shaped electromagnets 140 could each be slightly rotated about their longitudinal axes.
- the electromagnets along the longitudinal axis form a helix about the axis.
- the rotation of the magnetic field causes the field lines to sweep through the biological material in a circular manner and create a secondary, axial Lorentz current.
- the Lorentz current due to the lateral translation of the magnetic field is radial.
- the present invention includes an apparatus for transporting at least one medicant to humans and animals through a transdermal site.
- the apparatus includes a medicant supply located on the site and at least one permanent magnet in proximity to the site.
- a drive mechanism is disposed to move the magnet relative to the site to induce a direct electric field within the site by means of the movement of the magnetic field from the magnet, the electric field being of sufficient magnitude to increase the rate of transportation of the medicant.
- the medicant supply is a drug saturated pad 71 that can be held in place against the surface of the biological material.
- the transdermal portable, drug induction system includes a plate 72 for holding drug pad 71. The plate 72 rotates on hinge 73 to allow the placement or removal of the pad.
- the permanent magnet and drive mechanism are essentially the same as those disclosed in FIGS. 17 through 19.
- Dual enclosed magnetic disks 41 are mounted on bearings.
- the disks 41 are arranged to create a moving magnetic field that traverses the biological material and the drug saturated pad 71.
- the moving magnetic field exiting from windows 91 in magnetic shielding 90 and emanating from the opposite magnetic pole surfaces of annular disk magnets 41, transects drug saturated pad 71.
- the magnetic field causes ionic forms of the drug to penetrate the skin and tissue of the limb or body portion enclosed between drug pad 71 and cushion 74.
- One or both disks are driven by an electrical motor 50 and control circuit with a variable speed adjustment that allows a wide assortment of: rotary speeds; direction of rotation, and times of operation.
- the rotation of the driven magnet 41 connected to gear 95 causes the rotation of facing magnet of opposite polarity freewheeling on shaft 96.
- Housing 92 encloses the unit.
- the inner surfaces of the housing that are most proximate and parallel to the outermost faces of the magnetic disks are covered by magnetic shielding 90, which prevents the passage of the magnetic field except through such openings as are provided.
- the magnetic shielding preferably has two annular openings that allow the magnetic field to exit the housing surfaces and cause transdermal transport of the cations or anions of various drugs through the surface of the skin of the enclosed limb.
- the present invention includes an apparatus for transporting at least one medicant to humans and animals through a transdermal site.
- the apparatus includes a medicant supply located on the site and a sequential array of electromagnets in proximity to the site.
- a control device is disposed to sequentially apply a pulse of electrical current to each electromagnet in the array to generate a magnetic field in the electromagnet and, by the sequential activation of the electromagnets in the array, generate a moving magnetic field along the array thereby inducing a direct electric field within the material in proximity to the site, the electric field being of sufficient magnitude to increase the rate of transportation of the medicant.
- This embodiment of the invention is similar to the embodiment shown in FIGS. 20 and 21, except instead of using the system disclosed in FIGS.
- FIGS. 15 and 16 it uses the system disclosed in FIGS. 15 and 16. More specifically, one side of the array of the C-shaped electromagnets 140 shown in FIG. 15 replaces one of the magnetic disks 41 shown in FIG. 21, and the other side of the array of the electromagnets 140 replaces the other of the magnetic disks 41.
- Each of the above embodiments and numerous other possible configurations are based on the concept of a moving magnetic field generating an electric current in or on a biological material without the use of electrodes.
- Magnetic fields of 2000 gauss which can be achieved by both permanent and electromagnets, coupled with the velocities generated by electric motor rotational speeds, allow Lorentz forces that meet or exceed electric currents used by known devices.
- the systems preferably can generate an electric field in the biological material having a field strength in the range of from 0.001 V/Meter to 100.0 V/Meter.
- the systems also preferably generate a DC electric current in the biological material in the range of from 0.000001 to 10.0 amperes.
- the present invention generates DC currents for medical treatment while eliminating the risk to the patient caused by inserting electrodes.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Magnetic Treatment Devices (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU42916/96A AU4291696A (en) | 1994-11-18 | 1995-11-17 | Apparatus for inducing dc electric fields in biological material and method of using it |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34399394A | 1994-11-18 | 1994-11-18 | |
US08/343,993 | 1994-11-18 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO1996015829A2 true WO1996015829A2 (fr) | 1996-05-30 |
WO1996015829A9 WO1996015829A9 (fr) | 1996-07-25 |
WO1996015829A3 WO1996015829A3 (fr) | 1996-11-14 |
Family
ID=23348565
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1995/015811 WO1996015829A2 (fr) | 1994-11-18 | 1995-11-17 | Procede d'induction de champs electriques a courant continu dans une matiere biologique et procede d'utilisation |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4291696A (fr) |
WO (1) | WO1996015829A2 (fr) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0838236A2 (fr) * | 1996-10-25 | 1998-04-29 | Nihon Kohden Corporation | Appareil de stimulation magnétique pour un être vivant |
WO2005049135A1 (fr) | 2003-11-21 | 2005-06-02 | International Scientific Pty Ltd | Appareil et procede pour faciliter l'administration par voie transdermique de substances therapeutiques |
WO2012126044A1 (fr) * | 2011-03-18 | 2012-09-27 | University Of Technology, Sydney | Dispositif comprenant des configurations d'aimant mobile |
US20130150651A1 (en) * | 2007-09-25 | 2013-06-13 | Neosync, Inc. | Systems and methods for neuro-eeg synchronization therapy |
US8465408B2 (en) | 2009-08-06 | 2013-06-18 | Neosync, Inc. | Systems and methods for modulating the electrical activity of a brain using neuro-EEG synchronization therapy |
US8585568B2 (en) | 2009-11-12 | 2013-11-19 | Neosync, Inc. | Systems and methods for neuro-EEG synchronization therapy |
US8926490B2 (en) | 2008-09-24 | 2015-01-06 | Neosync, Inc. | Systems and methods for depression treatment using neuro-EEG synchronization therapy |
US9649502B2 (en) | 2011-11-14 | 2017-05-16 | Neosync, Inc. | Devices and methods of low frequency magnetic stimulation therapy |
US9962555B1 (en) | 2017-01-17 | 2018-05-08 | Neosync, Inc. | Head-mountable adjustable devices for generating magnetic fields |
US10471271B1 (en) | 2005-01-21 | 2019-11-12 | Michael Sasha John | Systems and methods of individualized magnetic stimulation therapy |
US10588576B2 (en) | 2014-08-15 | 2020-03-17 | Neosync, Inc. | Methods and device for determining a valid intrinsic frequency |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3221544A1 (de) * | 1982-06-08 | 1983-12-08 | Thomas 6551 Pfaffen-Schwabenheim Gensky | Magnetische therapievorrichtung |
DE3417773A1 (de) * | 1984-05-14 | 1985-02-14 | Alois 8000 München Hörl | Vorrichtung zur herstellung pulsierender magnetfelder fuer therapeutische zwecke |
DE3414938A1 (de) * | 1983-10-17 | 1985-04-25 | Alois 8000 München Hörl | Vorrichtung zur herstellung pulsierender magnetfelder fuer therapeutische zwecke |
FR2578428A1 (fr) * | 1985-03-08 | 1986-09-12 | Maguet Rene | Dispositif magnetique pour soulager les douleurs, produisant un champ magnetique en mouvement |
-
1995
- 1995-11-17 AU AU42916/96A patent/AU4291696A/en not_active Abandoned
- 1995-11-17 WO PCT/US1995/015811 patent/WO1996015829A2/fr active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3221544A1 (de) * | 1982-06-08 | 1983-12-08 | Thomas 6551 Pfaffen-Schwabenheim Gensky | Magnetische therapievorrichtung |
DE3414938A1 (de) * | 1983-10-17 | 1985-04-25 | Alois 8000 München Hörl | Vorrichtung zur herstellung pulsierender magnetfelder fuer therapeutische zwecke |
DE3417773A1 (de) * | 1984-05-14 | 1985-02-14 | Alois 8000 München Hörl | Vorrichtung zur herstellung pulsierender magnetfelder fuer therapeutische zwecke |
FR2578428A1 (fr) * | 1985-03-08 | 1986-09-12 | Maguet Rene | Dispositif magnetique pour soulager les douleurs, produisant un champ magnetique en mouvement |
Cited By (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0838236A2 (fr) * | 1996-10-25 | 1998-04-29 | Nihon Kohden Corporation | Appareil de stimulation magnétique pour un être vivant |
EP0838236A3 (fr) * | 1996-10-25 | 1999-12-01 | Nihon Kohden Corporation | Appareil de stimulation magnétique pour un être vivant |
WO2005049135A1 (fr) | 2003-11-21 | 2005-06-02 | International Scientific Pty Ltd | Appareil et procede pour faciliter l'administration par voie transdermique de substances therapeutiques |
EP1694408A1 (fr) * | 2003-11-21 | 2006-08-30 | International Scientific PTY Ltd | Appareil et procede pour faciliter l'administration par voie transdermique de substances therapeutiques |
EP1694408A4 (fr) * | 2003-11-21 | 2006-12-20 | Internat Scient Pty Ltd | Appareil et procede pour faciliter l'administration par voie transdermique de substances therapeutiques |
US8019412B2 (en) | 2003-11-21 | 2011-09-13 | International Scientific Pty Ltd. | Apparatus for facilitating transdermal delivery of therapeutic substances and method of transdermally delivering therapeutic substances |
US10471271B1 (en) | 2005-01-21 | 2019-11-12 | Michael Sasha John | Systems and methods of individualized magnetic stimulation therapy |
US9272159B2 (en) | 2007-09-25 | 2016-03-01 | Neosync, Inc. | Systems and methods for neuro-EEG synchronization therapy |
US11311741B2 (en) | 2007-09-25 | 2022-04-26 | Wave Neuroscience, Inc. | Systems and methods for anxiety treatment using neuro-EEG synchronization therapy |
US8475354B2 (en) | 2007-09-25 | 2013-07-02 | Neosync, Inc. | Systems and methods for neuro-EEG synchronization therapy |
US8480554B2 (en) | 2007-09-25 | 2013-07-09 | Neosync, Inc. | Systems and methods for depression treatment using neuro-EEG synchronization therapy |
US11938336B2 (en) | 2007-09-25 | 2024-03-26 | Wave Neuroscience, Inc. | Methods for treating anxiety using neuro-EEG synchronization therapy |
US8888672B2 (en) | 2007-09-25 | 2014-11-18 | Neosync, Inc. | Systems and methods for neuro-EEG synchronization therapy |
US8888673B2 (en) | 2007-09-25 | 2014-11-18 | Neosync, Inc. | Systems and methods for neuro-EEG synchronization therapy |
US8961386B2 (en) | 2007-09-25 | 2015-02-24 | Neosync, Inc. | Systems and methods for neuro-EEG synchronization therapy |
US9015057B2 (en) | 2007-09-25 | 2015-04-21 | Neosync, Inc. | Systems and methods for controlling and billing neuro-EEG synchronization therapy |
US20130150651A1 (en) * | 2007-09-25 | 2013-06-13 | Neosync, Inc. | Systems and methods for neuro-eeg synchronization therapy |
US9308387B2 (en) | 2007-09-25 | 2016-04-12 | Neosync, Inc. | Systems and methods for neuro-EEG synchronization therapy |
US8870737B2 (en) | 2008-09-24 | 2014-10-28 | Neosync, Inc. | Systems and methods for neuro-EEG synchronization therapy |
US8926490B2 (en) | 2008-09-24 | 2015-01-06 | Neosync, Inc. | Systems and methods for depression treatment using neuro-EEG synchronization therapy |
US9713729B2 (en) | 2009-08-06 | 2017-07-25 | Neosync, Inc. | Systems and methods for modulating the electrical activity of a brain using neuro-EEG synchronization therapy |
US10357660B2 (en) | 2009-08-06 | 2019-07-23 | Neosync, Inc. | Systems and methods for modulating the electrical activity of a brain using neuro-EEG synchronization therapy |
US8465408B2 (en) | 2009-08-06 | 2013-06-18 | Neosync, Inc. | Systems and methods for modulating the electrical activity of a brain using neuro-EEG synchronization therapy |
US20180126184A1 (en) * | 2009-08-06 | 2018-05-10 | Neosync, Inc. | Systems and methods for modulating the electrical activity of a brain using neuro-eeg synchronization therapy |
US10065048B2 (en) | 2009-11-12 | 2018-09-04 | Neosync, Inc. | Systems and methods for neuro-EEG synchronization therapy |
US10821293B2 (en) | 2009-11-12 | 2020-11-03 | Wave Neuroscience, Inc. | Systems and methods for neuro-EEG synchronization therapy |
US9446259B2 (en) | 2009-11-12 | 2016-09-20 | Neosync, Inc. | Systems and methods for neuro-EEG synchronization therapy |
US8585568B2 (en) | 2009-11-12 | 2013-11-19 | Neosync, Inc. | Systems and methods for neuro-EEG synchronization therapy |
US11975213B2 (en) | 2009-11-12 | 2024-05-07 | Wave Neuroscience, Inc. | Systems for neuro-EEG synchronization therapy |
US10293175B2 (en) | 2011-03-18 | 2019-05-21 | Peter Andrew Watterson | Device including moving magnet configurations |
WO2012126044A1 (fr) * | 2011-03-18 | 2012-09-27 | University Of Technology, Sydney | Dispositif comprenant des configurations d'aimant mobile |
US9649502B2 (en) | 2011-11-14 | 2017-05-16 | Neosync, Inc. | Devices and methods of low frequency magnetic stimulation therapy |
US10588576B2 (en) | 2014-08-15 | 2020-03-17 | Neosync, Inc. | Methods and device for determining a valid intrinsic frequency |
US9962555B1 (en) | 2017-01-17 | 2018-05-08 | Neosync, Inc. | Head-mountable adjustable devices for generating magnetic fields |
US10835754B2 (en) | 2017-01-17 | 2020-11-17 | Wave Neuroscience, Inc. | Head-mountable adjustable devices for generating magnetic fields |
US11998755B2 (en) | 2017-01-17 | 2024-06-04 | Wave Neuroscience, Inc. | Head-mountable adjustable devices for generating magnetic fields |
Also Published As
Publication number | Publication date |
---|---|
WO1996015829A3 (fr) | 1996-11-14 |
AU4291696A (en) | 1996-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20030093028A1 (en) | Appararus and method for magnetic induction of therapeutic electric fields | |
US7288062B2 (en) | Apparatus for creating therapeutic charge transfer in tissue | |
CN103619408B (zh) | 一种用于活化神经和/或肌肉的装置 | |
EP0906136B1 (fr) | Stimulateur nerveux magnetique destine a l'excitation des nerfs peripheriques | |
EP0189620A1 (fr) | Procédé et appareil pour la guérison de tissus | |
KR100960430B1 (ko) | 치료용 미소진동장치 | |
US6231497B1 (en) | Magnetic therapy device | |
US4177796A (en) | Magnetic thermal vibrational device for the treatment of arthritis and the like | |
EP2214781B1 (fr) | Appareil pour créer un transfert de charge thérapeutique dans un tissu | |
KR20030016417A (ko) | 말초 신경들을 자극하기 위한 자기 신경 자극기 | |
WO2003090863A1 (fr) | Bobine de stimulation faisant appel a un miroir magnetique et son utilisation | |
US10639494B2 (en) | Time-varying magnetic field therapy using multistable latching mechanisms | |
AU5745994A (en) | Magnetotherapy apparatus | |
WO1996015829A2 (fr) | Procede d'induction de champs electriques a courant continu dans une matiere biologique et procede d'utilisation | |
WO2009020938A1 (fr) | Réseaux multibobines monophasiques pour stimulation magnétique crânienne | |
WO1996015829A9 (fr) | Procede d'induction de champs electriques a courant continu dans une matiere biologique et procede d'utilisation | |
US6178079B1 (en) | Magnetic annunciator | |
CN106492351A (zh) | 一种交变永磁磁场的睡眠治疗仪及其运行方法 | |
EP1694408B1 (fr) | Appareil pour faciliter l'administration par voie transdermique de substances therapeutiques | |
US12208276B2 (en) | Method and apparatus generator, concentrator and router of electromagnetic fields for cellular regeneration | |
CN1013828B (zh) | 多功能穴位治疗装置 | |
GB2367007A (en) | Therapy device using combined static and dynamic magnetic fields | |
RU2045967C1 (ru) | Устройство для магнитотерапии | |
RU2273499C2 (ru) | Аппарат магнитной терапии | |
RU2262359C2 (ru) | Устройство для селективной магнитотерапии |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU BR CA CN CZ FI GE HU JP KR MX NO NZ PL RU SG UA VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 12/13 AND 13/13, DRAWINGS, REPLACED BY NEW PAGES BEARING THE SAME NUMBER;AFTER RECTIFICATION OF OBVIOUS ERRORS AS AUTHORIZED BY THE INTERNATIONAL SEARCHING AUTHORITY |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU BR CA CN CZ FI GE HU JP KR MX NO NZ PL RU SG UA VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
NENP | Non-entry into the national phase in: |
Ref country code: CA |
|
122 | Ep: pct application non-entry in european phase |